Clinical trial
A Phase I Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profile of Intramuscular or Subcutaneous Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659 is registered in ClinicalTrials.gov with Premier Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profile of Intramuscular or Subcutaneous Injections of Levonorgestrel Butanoate (LB) for Female Contraception
- Lead sponsor
- Premier Research
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- March 3, 2020
- Completion date
- March 26, 2026
- Enrollment
- 136 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
female contraception, healthy women